- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02310893
Effectiveness of Peer Navigation and Contingency Management on Retention in HIV Care (CHAMPS)
November 16, 2020 updated by: University of California, Los Angeles
Consistent treatment with anti-retroviral therapy (ART) suppresses viral load (VL), prolonging life and improving quality of life for HIV+ persons.
Suppressing VL benefits communities by reducing transmission to others.
Mere availability of ART and care, however, is insufficient; the benefits of ART depend upon HIV+ persons' continuous visits to the health care provider, regular monitoring and regular delivery of medications, - known as retention in HIV care.
In spite of national efforts, up to a quarter of HIV+ persons, especially low-income minorities are out of care.
Innovative interventions are therefore urgently needed to maximize engagement and retention in HIV care, self-reported adherence, as well as HIV-1 RNA viral load suppression.
In pursuit of these aims, the proposed study will assess outcomes of the following interventions in comparison to usual care: 1) contingency management (CM) only; 2) peer navigation (PN) only; and 3) a combined approach that integrates both CM and PN (CA) which the investigators hypothesize to be most effective in improving HIV clinical outcomes.
Study Overview
Status
Completed
Conditions
Study Type
Interventional
Enrollment (Actual)
579
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
California
-
Los Angeles, California, United States, 90059
- OASIS Clinic
-
Los Angeles, California, United States, 90012
- Center for Health Justice
-
Los Angeles, California, United States, 90012
- Los Angeles Sheriff's Department
-
Los Angeles, California, United States, 90022
- AltaMed Health Services Corporation
-
Sylmar, California, United States, 91342
- Olive View Medical Center
-
Van Nuys, California, United States, 91401
- Northeast Valley Health Corporation
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Diagnosed HIV+
- Age 18 years or older
- English or Spanish speaking
- Residence in Los Angeles County
- prescribed ART in prior 24 months
- < 3 visits in prior 12 months or have detectable viral load, as identified in the Ryan White CaseWatch database
Exclusion Criteria:
Not meeting any of the criteria identified above
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Health Services Research
- Allocation: Randomized
- Interventional Model: Factorial Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Active Comparator: Contingency Management only
Participants assigned to this arm will receive payments for attending regular HIV medical appointments at the clinic and filling prescribed HIV medications at the pharmacy
|
|
Active Comparator: Peer Navigation only
Participants in this arm will be assigned a peer navigator to assist them in accessing and remaining in HIV care
|
|
Experimental: Combined Contingency Management and Peer Navigation
Participants in this arm will be assigned a peer navigator to assist them in accessing and remaining in HIV care and will be eligible to receive incentives for attending HIV care visits/refilling prescriptions.
|
|
No Intervention: Usual care
Participants in this arm will receive the care that they would usually get in their clinic in the absence of this study.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Change in retention-in-care behaviors over 12 months
Time Frame: Basline, follow-ups at month 2, 6, 12
|
Using a 2x2 factorial design, to examine the effect of the three interventions -- peer navigation, contingency management, combined approach and usual care -- and evaluate how well they improve retention in HIV care
|
Basline, follow-ups at month 2, 6, 12
|
Change in HIV RNA viral load suppression and medication adherence over 12 months
Time Frame: Basline, follow-ups at month 2, and 12
|
Using the same design, to examine the effects of the PN, CM and, CA interventions on HIV RNA viral load suppression and self-reported adherence
|
Basline, follow-ups at month 2, and 12
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Cost effectiveness
Time Frame: 5 years
|
A secondary aim is to examine the cost-offset and potential cost-effectiveness of each intervention compared with usual care
|
5 years
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Investigators
- Principal Investigator: William Cunningham, MD, MPH, University of California, Los Angeles
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
January 1, 2016
Primary Completion (Actual)
December 1, 2019
Study Completion (Actual)
January 1, 2020
Study Registration Dates
First Submitted
July 18, 2014
First Submitted That Met QC Criteria
December 4, 2014
First Posted (Estimate)
December 8, 2014
Study Record Updates
Last Update Posted (Actual)
November 17, 2020
Last Update Submitted That Met QC Criteria
November 16, 2020
Last Verified
November 1, 2020
More Information
Terms related to this study
Additional Relevant MeSH Terms
- RNA Virus Infections
- Virus Diseases
- Infections
- Blood-Borne Infections
- Communicable Diseases
- Sexually Transmitted Diseases, Viral
- Sexually Transmitted Diseases
- Lentivirus Infections
- Retroviridae Infections
- Immunologic Deficiency Syndromes
- Immune System Diseases
- Slow Virus Diseases
- HIV Infections
- Acquired Immunodeficiency Syndrome
Other Study ID Numbers
- 1R01MH103076-01A1 (U.S. NIH Grant/Contract)
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on HIV/AIDS
-
University of MinnesotaWithdrawnHIV Infections | HIV/AIDS | Hiv | AIDS | Aids/Hiv Problem | AIDS and InfectionsUnited States
-
University of California, San DiegoNational Institute of Allergy and Infectious Diseases (NIAID)Completed
-
University of Massachusetts, BostonCompleted
-
Stanford UniversityJanssen Services, LLCCompleted
-
ViiV HealthcareJohns Hopkins University; Pfizer; Vanderbilt University; University of North Carolina...Completed
-
Medical College of WisconsinCompleted
-
Emory UniversityCompleted
-
Rhode Island HospitalUnknown
-
Tibotec Pharmaceuticals, IrelandCompleted
-
Lampiris, Harry W., M.D.AbbottUnknown
Clinical Trials on Contingency Management
-
VA Office of Research and DevelopmentRecruitingPTSD | Cannabis-Related DisorderUnited States
-
Johns Hopkins UniversityJohns Hopkins Community PhysiciansWithdrawnSubstance-related DisorderUnited States
-
UConn HealthNational Institute on Drug Abuse (NIDA)Completed
-
UConn HealthNational Institute on Drug Abuse (NIDA)Completed
-
UConn HealthNational Institute on Drug Abuse (NIDA)Completed
-
UConn HealthNational Institute on Drug Abuse (NIDA)CompletedContingency Management | Exercise | Substance AbuseUnited States
-
Washington State UniversityCompleted
-
The University of Texas Health Science Center at...National Institute on Drug Abuse (NIDA); National Institutes of Health (NIH)Completed
-
Douglas Mental Health University InstituteRecruitingPsychotic Disorders | Cognitive Dysfunction | Cannabis Dependence | Cannabis Use | Memory Impairment | Schizophrenia; Psychosis | Cannabis Use Disorder | NeuroimagingCanada
-
University of Colorado, DenverUniversity of Colorado, BoulderEnrolling by invitation